Eli Lilly Announces Cheaper Option For Insulin In Response To Drug Price Outcry

Unable to load the audio player.
You could try direct download?

Original story from IPBS-RJC

Jill Sheridan

Article origination IPBS-RJC

Eli Lilly's headquarters in Indianapolis.
*Lauren Chapman/IPB News*

Indianapolis-based drug company Eli Lilly says it will soon start selling a cheaper insulin for diabetic patients. The move comes amid outcry over high drug prices.

The new insulin is a generic version of Lilly’s popular Humalog. A vial will be sold for $137, half the price of the name brand version Humalog. Five-pack KwikPens will be $265.

The soaring cost of insulin has been the focus of recent campaigns that highlight how patients struggle to afford the medicine they need to live. Some federal and state leaders have begun to pressure companies to lower drug prices.

Eli Lilly and other insulin manufacturers point to pharmacy benefit negotiations and new developments as some of the reasons for high prices.

"The significant rebates we pay on insulins do not directly benefit all patients. This needs to change," said David Ricks, Lilly’s chairman and CEO in a statement.

The company said it will work to make the new, cheaper insulin available as soon as possible.

Support independent journalism today. You rely on WFYI to stay informed, and we depend on you to make our work possible. Donate to power our nonprofit reporting today. Give now.

FSSA creates waitlist for Aged and Disabled waiver. Advocates worry it creates barrier to care

Hoosiers with disabilities or who want to age in place may have a harder time accessing services under an important Medicaid waiver. The Family and Social Services Administration will implement a waitlist for the Aged and Disabled waiver, as part of its effort to address the states Medicaid shortfall.

Health / March 25, 2024

What's at stake in the Supreme Court mifepristone case

The case could affect not just abortion access, but oversight of the drug industry and the authority of federal agencies. The court hears arguments Tuesday.

Health / March 9, 2024

Psilocybin research fund, pharmacy benefits manager language added to nursing bill

Legislation headed to the governor would simplify requirements for nursing instructors and increase transparency around pharmacy benefits managers. The bill would also establish a research fund for psilocybin a chemical compound found in some psychedelic mushrooms.